{"id":689046,"date":"2022-09-27T06:38:02","date_gmt":"2022-09-27T10:38:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/"},"modified":"2022-09-27T06:38:02","modified_gmt":"2022-09-27T10:38:02","slug":"teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/","title":{"rendered":"Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio"},"content":{"rendered":"<h2>\nMidline options designed to fit the needs of clinicians and patients<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>WAYNE, Pa., Sept.  27, 2022  (GLOBE NEWSWIRE) &#8212; Teleflex Incorporated (NYSE: TFX) releases their new Arrow<sup>\u00ae<\/sup> Pressure Injectable Midline portfolio in the US and Canada, designed to help alleviate line identification confusion. Clinicians can choose between the Arrowg+ard Blue Advance<sup>\u00ae <\/sup>Midline with antimicrobial and antithrombogenic protection or the traditional Arrow<sup>\u00ae<\/sup> Midline, both of which are available in single and double lumen options.<sup>1,2<\/sup><\/p>\n<p>Without quick and easy identification between midlines and PICCs, clinicians may mistakenly infuse medications through midlines that should only be infused through a central venous access device. These complications can cause disruption in patient therapy and, if serious, could lead to line replacement.<\/p>\n<p>Teleflex conducted extensive research with industry-leading vascular access professionals to select the enhancements in the new Arrow<sup>\u00ae<\/sup> Midline Catheters. Clinician-inspired updates to the portfolio include:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">Eye catching, yellow colored catheter features and labeling to help reduce line confusion and promote patient safety<\/li>\n<li style=\"margin-bottom:8pt\">A robust offering of 14 different kit configurations, all with pressure injection capabilities to facilitate procedural efficiency and mitigate risks<\/li>\n<li style=\"margin-bottom:8pt\">A new Arrow<sup>\u00ae<\/sup> ergonomic trimmer that allows for multiple precise cuts and easy visualization<\/li>\n<li style=\"margin-bottom:8pt\">Premium components available such as one-piece, full-body fenestrated drape, ultrasound probe cover with gel, and Tegaderm\u2122 CHG Securement Dressing<\/li>\n<\/ul>\n<p>\u201cThe Arrowg+ard Blue Advance<sup>\u00ae<\/sup> Midline catheter portfolio provides protection by reducing thrombus accumulation and the primary pathogens responsible for most healthcare associated infections<sup>1,2.<\/sup> With multiple levels of protection, critical innovations, and a streamlined workflow, it\u2019s the perfect solution to deliver vital medications.\u201d said Lisa Kudlacz, President and General Manager, Vascular Access Division.<\/p>\n<p>\n        <strong>About Teleflex Incorporated<\/strong><br \/>\n        <br \/>Teleflex is a global provider of medical technologies designed to improve the health and quality of people\u2019s lives. We apply purpose driven innovation \u2013 a relentless pursuit of identifying unmet clinical needs \u2013 to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=l6igoosIZwwqjcv0nIOr_k_S1CzVnInhwcdDxOLsU85I4q7vcNwZ7orPoFpFDS0kGWPkoRR9WA6dDUy7CvaXUUGaLZ-kFOqEt5hqHInQXkvTlFyflrtCt8scIsk8LEe1J5WU3lOkjyxgYJBCPSRcTdlTkOBD6IJthZdiRaqV_bO-xtquSKLvl0hezD29fw8MxS9tdBq9jxRM_h0O0-r0uBOwcX_gFjW77SJoQUoG0dI5Wi2prT4FQkWqOblQafJsRqnZzDXLpjRLcUbt7LyTbWlxfkrqRXndRz8xXFBJgWoqS9q2i2CclWsVBsSQ8dW4\" rel=\"nofollow noopener\" target=\"_blank\">teleflex.com<\/a>.<\/p>\n<p>Teleflex is the home of Arrow<sup>\u00ae<\/sup>, Deknatel<sup>\u00ae<\/sup>, LMA<sup>\u00ae<\/sup>, Pilling<sup>\u00ae<\/sup>, QuikClot<sup>\u00ae<\/sup>, R\u00fcsch<sup>\u00ae<\/sup>, UroLift<sup>\u00ae<\/sup>, and Weck<sup>\u00ae<\/sup> \u2013 trusted brands united by a common sense of purpose.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong><br \/>\n        <br \/>Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management&#8217;s current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.<\/p>\n<p>\n        <strong>References:<\/strong>\n      <\/p>\n<ol style=\"list-style-type:decimal\">\n<li style=\"margin-top:5pt;margin-bottom:5pt\">\n          <em>In vitro<\/em> data on file 2010: AVER-004371 and AVER-004483. No correlation between <em>in vitro\/in vivo<\/em> testing methods and clinical outcomes have currently been ascertained.<\/li>\n<li style=\"margin-top:5pt;margin-bottom:5pt\">As compared to uncoated PICCs, intravascular ovine model inoculated with <em>Staph aureus<\/em>: AVAR-000427. No correlation between <em>in vitro\/in vivo<\/em> testing methods and clinical outcomes have currently been ascertained.<\/li>\n<\/ol>\n<p>\n        <em>Rx only<\/em>\n      <\/p>\n<p>Contraindication:<\/p>\n<p>Clinical assessment of the patient must be completed to ensure no contraindications exist. The Arrowg+ard Blue Advance\u00ae Midline is contraindicated in the following areas:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:8pt\">Patients with known hypersensitivity to chlorhexidine<\/li>\n<li style=\"margin-bottom:8pt\">In presence of device related infections<\/li>\n<li style=\"margin-bottom:8pt\">In presence of previous or current thrombosis in the intended vessel or along the catheterized vessel pathway.<\/li>\n<\/ul>\n<p>No correlation between <em>in vitro\/in vivo<\/em> testing methods and clinical outcomes have currently been ascertained.<\/p>\n<p>Tegaderm is a registered trademark of 3M or its affiliates.<\/p>\n<p>\n        <em>Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Advance, Deknatel, LMA, Pilling, QuikClot, Rusch, UroLift, and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and\/or other countries. All other marks are the property of their respective owners.<\/em><br \/>\n        <br \/>\n        <em>\u00a9 2022 Teleflex Incorporated. All rights reserved. MC-008282<\/em>\n      <\/p>\n<p>\n        <strong>Contracts: <\/strong><br \/>\n        <br \/>Teleflex Incorporated:<br \/>Lawrence Keusch<br \/>Vice President, Investor Relations and Strategy Development<\/p>\n<p>John Hsu, CFA<br \/>Vice President, Investor Relations<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=G1Vd4FVePykAWj23X_vnjnIuh7G5Pwm4mnaGE35V_iv_BZfDWx2mF_CQCnDH84yAfbEl1-Rubr7svnUlMLU-JFsHsvijithK1dZX_KZT_x4=\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <u>investors.teleflex.com<\/u><br \/>\n        <\/a><br \/>\n        <br \/>610-948-2836<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjMzNCM1MTQwNjY0IzIwMDQ2NTA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/YmJiOTlkYjYtNWVhMS00NjNkLWIyZmQtZDUzNWEwYTUyOWExLTEwMTYyMjM=\/tiny\/Teleflex-Incorporated.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Midline options designed to fit the needs of clinicians and patients WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) &#8212; Teleflex Incorporated (NYSE: TFX) releases their new Arrow\u00ae Pressure Injectable Midline portfolio in the US and Canada, designed to help alleviate line identification confusion. Clinicians can choose between the Arrowg+ard Blue Advance\u00ae Midline with antimicrobial and antithrombogenic protection or the traditional Arrow\u00ae Midline, both of which are available in single and double lumen options.1,2 Without quick and easy identification between midlines and PICCs, clinicians may mistakenly infuse medications through midlines that should only be infused through a central venous access device. These complications can cause disruption in patient therapy and, if serious, could lead to line replacement. Teleflex conducted extensive research &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-689046","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Midline options designed to fit the needs of clinicians and patients WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) &#8212; Teleflex Incorporated (NYSE: TFX) releases their new Arrow\u00ae Pressure Injectable Midline portfolio in the US and Canada, designed to help alleviate line identification confusion. Clinicians can choose between the Arrowg+ard Blue Advance\u00ae Midline with antimicrobial and antithrombogenic protection or the traditional Arrow\u00ae Midline, both of which are available in single and double lumen options.1,2 Without quick and easy identification between midlines and PICCs, clinicians may mistakenly infuse medications through midlines that should only be infused through a central venous access device. These complications can cause disruption in patient therapy and, if serious, could lead to line replacement. Teleflex conducted extensive research &hellip; Continue reading &quot;Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-27T10:38:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjMzNCM1MTQwNjY0IzIwMDQ2NTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio\",\"datePublished\":\"2022-09-27T10:38:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\\\/\"},\"wordCount\":689,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0MjMzNCM1MTQwNjY0IzIwMDQ2NTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\\\/\",\"name\":\"Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0MjMzNCM1MTQwNjY0IzIwMDQ2NTA=\",\"datePublished\":\"2022-09-27T10:38:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0MjMzNCM1MTQwNjY0IzIwMDQ2NTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0MjMzNCM1MTQwNjY0IzIwMDQ2NTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/","og_locale":"en_US","og_type":"article","og_title":"Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio - Market Newsdesk","og_description":"Midline options designed to fit the needs of clinicians and patients WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) &#8212; Teleflex Incorporated (NYSE: TFX) releases their new Arrow\u00ae Pressure Injectable Midline portfolio in the US and Canada, designed to help alleviate line identification confusion. Clinicians can choose between the Arrowg+ard Blue Advance\u00ae Midline with antimicrobial and antithrombogenic protection or the traditional Arrow\u00ae Midline, both of which are available in single and double lumen options.1,2 Without quick and easy identification between midlines and PICCs, clinicians may mistakenly infuse medications through midlines that should only be infused through a central venous access device. These complications can cause disruption in patient therapy and, if serious, could lead to line replacement. Teleflex conducted extensive research &hellip; Continue reading \"Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-27T10:38:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjMzNCM1MTQwNjY0IzIwMDQ2NTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio","datePublished":"2022-09-27T10:38:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/"},"wordCount":689,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjMzNCM1MTQwNjY0IzIwMDQ2NTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/","name":"Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjMzNCM1MTQwNjY0IzIwMDQ2NTA=","datePublished":"2022-09-27T10:38:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjMzNCM1MTQwNjY0IzIwMDQ2NTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0MjMzNCM1MTQwNjY0IzIwMDQ2NTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/teleflex-launches-new-arrow-pressure-injectable-midline-catheter-portfolio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Teleflex launches new Arrow\u00ae Pressure Injectable Midline Catheter Portfolio"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/689046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=689046"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/689046\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=689046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=689046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=689046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}